Guess which ASX healthcare share is rocketing 67% on a US hospital deal

Here are the details of the company's new hospital contract.

| More on:
A person with a round-mouthed expression clutches a device screen and looks shocked and surprised.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • This healthcare share is soaring 67% today
  • The company has signed its maiden US hospital Software as a Service contract 
  • The healthcare sector is up 1.03% in late trading

This ASX healthcare share is rocketing ahead on the market today.

The 4DMedical Ltd (ASX: 4DX) share price is up 66.7% on yesterday's closing price, currently trading at an intraday high of 52.5 cents. It closed trading yesterday at 31.5 cents a share.

For perspective, the S&P/ASX 200 Healthcare Index (ASX: XHJ) is up 1.03% in late afternoon trade.

Let's take a look at why this ASX healthcare share is booming today.

New five year contract

Investors appear to be buying up 4DMedical shares on the back of news it has signed its "first US hospital Software as a Service (SaaS) contract".

The company has signed a five-year contract with the University of Miami to deliver X-ray velocimetry lung ventilation analysis software ventilation reports.

Under the contract, 4DMedical will provide XV technology to the university to process patient data.

The deal represents a "significant milestone" for the company's commercialisation strategy in the United States.

Commenting on the news, 4DMedical and founder Andreas Fouras said:

Today's announcement of our first US SaaS contract reflects the attainment of a key milestone in the company's commercialisation journey.

Furthermore, the fact this milestone was completed with our clinical trial partners at the University of Miami, who have developed such an extensive understanding of XV Technology, is especially satisfying.

Share price snapshot

Even with today's boost, the 4DMedical share price has fallen 37% in the last year.

This ASX healthcare share has a market capitalisation of $141 million based on the current share price.

Motley Fool contributor Monica O'Shea has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Healthcare Shares

Guess which ASX small cap stock is jumping on 'significant milestone'

This stock is ending the week in style. Let's see what is giving its shares a boost today.

Read more »

Healthcare Shares

Are CSL and this ASX 200 healthcare stock buys in January?

Is now a good time to pick up these shares? Let's see what analysts are saying.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Communication Shares

2 ASX shares expected to report strong earnings this quarter

Analysts expect a strong set of upcoming numbers for these ASX heavyweights

Read more »

A women has her eyes checked at the optometrist.
Healthcare Shares

Is Medibank stock a good buy?

Can this company provide healthy returns?

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on US FDA approval news

This share is giving its shareholders an early Christmas present.

Read more »

A senior pharmacist talks to a customer at the counter in a shop
Healthcare Shares

Is it too late to buy Sigma shares to cash in on the Chemist Warehouse deal?

Can investors still make healthy returns with this stock?

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »